Key result
The hERG G487R mutation does not increase susceptibility to class III antiarrhythmics or hypokalemia versus wild-type.
Why the study?
The effects of arrhythmogenic factors on the hERG(G487R) mutant channel and its potential to exacerbate channel malfunction were unknown.
Does the hERG(G487R) mutation exacerbate hERG channel malfunction induced by arrhythmogenic factors compared to wild-type hERG?
Does the hERG(G487R) mutation exacerbate hERG channel malfunction induced by arrhythmogenic factors compared to wild-type hERG?
The hERG(G487R) mutation does not appear to increase the risk of arrhythmic disorders induced by antiarrhythmic drugs or hypokalemia compared to wild-type channels.
hERG(G487R) does not heighten drug- or hypokalemia-induced arrhythmia risk in vitro; leaves open clinical relevance for carriers.
The human ether-à-go-go-related gene (hERG) channel mediates the rapid delayed rectifier potassium current (IKr) responsible for shaping the repolarization phase of cardiac action potentials. hERG mutation may cause hERG channel malfunction, leading to long QT syndrome and other arrhythmic disorders. Elucidation of the genotype-phenotype relationships of individual hERG mutations is key to the development of treatment for such arrhythmic disorders. We previously identified hERG(G487R), a missense mutant with a glycine-to-arginine substitution at position 487. In the absence of arrhythmogenic factors, hERG(G487R) subunit-containing channels show normal surface expression and gating kinetics. However, it remains unknown whether the mutation exacerbates hERG channel malfunction induced by arrhythmogenic factors. Here we used a voltage-clamp technique to compare the effects of the major arrythmogenic factors on wild-type hERG [hERG(WT)] and hERG(G487R) channel currents (IhERG) in HEK-293T cells. The extent of IhERG blockade by the antiarrhythmic drug dofetilide or E4031 was not different between these channels. On the other hand, the extracellular K(+) concentration ([K(+)]ex)-dependent changes in the rates of recovery from inactivation and deactivation of IhERG were rather less obvious for hERG(G487R) channel than for hERG(WT) channel. These findings suggest that the inheritance of hERG(G487R) does not increase the risk of arrhythmic disorders induced by antiarrhythmic drugs or hypokalemia.
No takes yet. Share an insight, caveat, or question.
Hisajima et al. (2015) studied hERG channel mutation (G487R). Arrhythmogenic factors (dofetilide, E4031, hypokalemia) vs. Wild-type hERG channel was evaluated on Reduction in IhERG tail current by 30 nM E4031 (p=>0.05). The G487R mutation in the hERG channel does not increase susceptibility to blockade by class III antiarrhythmic drugs or gating modulations induced by hypokalemia compared to wild-type channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: